Home/Filings/4/0001213900-22-014564
4//SEC Filing

Nolet Chris 4

Accession 0001213900-22-014564

CIK 0001788028other

Filed

Mar 22, 8:00 PM ET

Accepted

Mar 23, 6:01 PM ET

Size

5.6 KB

Accession

0001213900-22-014564

Insider Transaction Report

Form 4
Period: 2022-03-21
Nolet Chris
Director
Transactions
  • Award

    Stock Option (right to buy)

    2022-03-21+78,04578,045 total
    Exercise: $3.54Exp: 2032-03-21Voting Common Stock (78,045 underlying)
Footnotes (1)
  • [F1]1/3rd of the shares subject to the option shall vest on December 7, 2022, and 1/3rd of the shares subject to the option shall vest on each anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001782814

Filing Metadata

Form type
4
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 6:01 PM ET
Size
5.6 KB